
Health Catalyst (($HCAT)) has held its Q3 earnings call. Read on for the main highlights of the call. Health Catalyst’s third-quarter earnings call carried a moderately positive tone as the
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| HCAT | Health Catalyst | 1.29 | -0.74 | -36.45% |
| Name | Price | % Change | |
|---|---|---|---|
| $1.29 | -36.45% |

Health Catalyst (($HCAT)) has held its Q3 earnings call. Read on for the main highlights of the call. Health Catalyst’s third-quarter earnings call carried a moderately positive tone as the

Reports Q3 revenue $56.28M, consensus $55.38M. “We delivered a third quarter above the high end of our revenue and Adjusted EBITDA guidance, and we are reaffirming our full-year outlook,” said

The latest announcement is out from Health Catalyst ( ($HCAT) ). On September 11, 2026, Health Catalyst appointed Tami Reller to its board of directors as a Class III director,

Health Catalyst (HCAT) announced that Simeon Kohl has been appointed CEO and president and a member of the company’s board of directors, effective September 14. Simeon Kohl most recently served

Health Catalyst ( ($HCAT) ) has issued an announcement. On September 4, 2026, Health Catalyst’s board appointed Simeon Kohl as chief executive officer, president and director, with his leadership roles

Health Catalyst (($HCAT)) has held its Q2 earnings call. Read on for the main highlights of the call. Health Catalyst’s latest earnings call carried a cautiously optimistic tone, blending solid

Canaccord downgraded Health Catalyst (HCAT) to Hold from Buy with a price target of $1.80, down from $3. The company is working through uncertainty around churn and down-sell risk among

Canaccord analyst Richard Close downgraded Health Catalyst (HCAT) to Hold from Buy with a price target of $1.80, down from $3. Published first on TheFly – the ultimate source for

Citi analyst Daniel Grosslight lowered the firm’s price target on Health Catalyst (HCAT) to $2 from $2.50 and keeps a Neutral rating on the shares. The firm updated its ratings

Health Catalyst (HCAT) announced it closed the sale of Vitalware, through which the company conducted its Vitalware business, to Med-Metrix, a technology-enabled revenue cycle management company, on July 31. The
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| hold | Reiterated | Nov 10, 2026 | ||||
| hold | Reiterated | Nov 8, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 | ||||
| hold | Reiterated | Sep 9, 2026 | ||||
| hold | Reiterated | Aug 10, 2026 | ||||
| hold | Reiterated | Aug 7, 2026 | ||||
| hold | Reiterated | May 12, 2026 | ||||
| hold | Reiterated | May 12, 2026 | ||||
| hold | Reiterated | May 8, 2026 | ||||
| hold | Reiterated | Mar 30, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 2, 2027TBA | $98.24M | $-0.05 | $50.60M | -0.01 | -0.46 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.